TAVR and Dialysis Are a Challenging Combination. A Case Report and Systematic Review of Literature

References

• Ureña-Torres P, D’Marco L, Raggi P, et al. Valvular heart disease and calcification in CKD: more common than appreciated. Nephrol Dial Transplant. 2020;35(12):2046–2053. doi:https://doi.org/10.1093/ndt/gfz133.
   Google Scholar
• Nashef SAM, Roques F, Sharples LD, et al. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41:734–745. doi:https://doi.org/10.1093/ejcts/ezs043.
   PubMed Web of Science ®Google Scholar
• O’Brien SM, Shahian DM, Filardo G, et al. The society of thoracic surgeons 2008 cardiac surgery risk models: part 2—isolated valve surgery. Ann Thorac Surg. 2009;88:S23–S42. doi:https://doi.org/10.1016/j.athoracsur.2009.05.056.
   Web of Science ®Google Scholar
• Paloian NJ, Giachelli CM. A current understanding of vascular calcification in CKD. Am J Physiol Ren Physiol. 2014;307(8):F891–F900. doi:https://doi.org/10.1152/ajprenal.00163.2014.
   PubMed Web of Science ®Google Scholar
• Cote N, Pibarot P, Clavel MA. Incidence, risk factors, clinical impact,and management of bioprosthesis structural valve degeneration. Curr Opin Cardiol. 2017;32:123–129. doi:https://doi.org/10.1097/HCO.0000000000000372.
   PubMed Web of Science ®Google Scholar
• George B. TAVR in patients with end-stage renal disease and critical aortic stenosis. J Am Coll Cardiol. 2019;73:2816–2818. doi:https://doi.org/10.1016/j.jacc.2019.04.007.
   Web of Science ®Google Scholar
• Bourget JM, Zegdi R, Lin J, et al. Correlation between structural changes and acute thrombogenicity in transcatheter pericardium valves after crimping and balloon deployment. Morphologie. 2017;101:19–32. doi:https://doi.org/10.1016/j.morpho.2016.06.003.
   PubMedGoogle Scholar
• Abdel-Wahab M, Mehilli J, Frerker C, et al. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. Jama. 2014;311(15):1503–1514. doi:https://doi.org/10.1001/jama.2014.3316.
   PubMed Web of Science ®Google Scholar
• Bonow RO, Carabello B, De Leon AC, et al. ACC/AHA guidelines for the management of patients with valvular heart disease. Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). J Heart Valve Dis. 1998;7:672–707.
   PubMedGoogle Scholar
• van Walraven C, Manuel DG, Knoll G. Survival trends in ESRD patients compared with the general population in the United States. Am J Kidney Dis. 2014;63:491–499. doi:https://doi.org/10.1053/j.ajkd.2013.09.011.
   PubMed Web of Science ®Google Scholar
• Herzog CA, Ma JZ, Collins AJ. Long-term survival of dialysis patients in the United States with prosthetic heart valves: should ACC/AHA practice guidelines on valve selection be modified? Circulation. 2002;105:1336–1341. doi:https://doi.org/10.1161/hc1102.100075.
   PubMed Web of Science ®Google Scholar
• Shroff GR, Bangalore S, Bhave NM; American Heart Association Council on the Kidney in Cardiovascular Disease and Stroke Council, et al. Evaluation and management of aortic stenosis in chronic kidney disease: a scientific statement from the American Heart Association. Circulation. 2021 May 13;143: CIR0000000000000979. doi:https://doi.org/10.1161/CIR.0000000000000979. PMID: 33980041.
   Google Scholar
• Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370:1790–1798. doi:https://doi.org/10.1056/NEJMoa1400590.
   PubMed Web of Science ®Google Scholar
• Makkar RR, Fontana GP, Jilaihawi H, et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012;366:1696–1704. doi:https://doi.org/10.1056/NEJMoa1202277.
   PubMed Web of Science ®Google Scholar
• Szerlip, M, Zajarias A, Vemalapalli S, et al. Transcatheter aortic valve replacement in patients with end-stage renal disease. J Am Coll Cardiol. 2019;73:2806–2815. doi:https://doi.org/10.1016/j.jacc.2019.03.496.
   Web of Science ®Google Scholar
• Szerlip M, Kim RJ, Adeniyi T, et al. The outcomes of transcatheter aortic valve replacement in a cohort of patients with end-stage renal disease. Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv. 2016;87:1314–1321. doi:https://doi.org/10.1002/ccd.26347
   Web of Science ®Google Scholar
• Codner P, Levi A, Gargiulo G, et al. Impact of renal dysfunction on results of transcatheter aortic valve replacement outcomes in a large multicenter cohort. Am J Cardiol. 2016;118:1888–1896. doi:https://doi.org/10.1016/j.amjcard.2016.08.082.
   Web of Science ®Google Scholar
• O’Hair DP, Bajwa TK, Chetcuti SJ, et al. One-year outcomes of transcatheter aortic valve replacement in patients with end-stage renal disease. Ann Thorac Surg. 2017;103:1392–1398. doi:https://doi.org/10.1016/j.athoracsur.2016.11.061.
   Web of Science ®Google Scholar
• Gupta T, Goel K, Kolte D, et al. Association of chronic kidney disease with in-hospital outcomes of transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2017;10:2050–2060. doi:https://doi.org/10.1016/j.jcin.2017.07.044.
   Web of Science ®Google Scholar
• Conrotto F, Salizzoni S, Andreis A, et al. Transcatheter aortic valve implantation in patients with advanced chronic kidney disease. Am J Cardiol. 2017;119(9):1438–1442. doi:https://doi.org/10.1016/j.amjcard.2017.01.042.
   PubMed Web of Science ®Google Scholar
• Long A, Mahoney P. Increased rate of intermediate-term valve failure after TAVR in end-stage renal disease patients requiring maintenance dialysis. J Invasive Cardiol. 2019;31:307–313.
   PubMed Web of Science ®Google Scholar
• Ruge H, Deutsch M-A, Erlebach M, et al. TAVR in patients on hemodialysis: outcome of a high-risk patient group. Heart Surg Forum. 2020;23:E611–E616. doi:https://doi.org/10.1532/hsf.3129.
   Web of Science ®Google Scholar
• Khan MZ, Khan MU, Kalra A, et al. Transcatheter versus surgical aortic valve replacement in patients with end stage renal disease. Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv. 2020;96:1102–1109. doi:https://doi.org/10.1002/ccd.29109
   Web of Science ®Google Scholar
• Mentias, A, Milind YD, Marwan S, et al. Management of aortic stenosis in patients with end-stage renal disease on hemodialysis. Circ Cardiovasc Interv. 2020;13:e009252. doi:https://doi.org/10.1161/CIRCINTERVENTIONS.120.009252.
   Web of Science ®Google Scholar
• Fukuhara S, Brescia AA, Shiomi S, et al. Surgical explantation of transcatheter aortic bioprostheses: results and clinical implications. J Thorac Cardiovasc Surg. 2020;162:539–547.e1. doi:https://doi.org/10.1016/j.jtcvs.2019.11.139.
   Google Scholar
• Hirji SA, Percy ED, McGurk S, et al. Incidence, characteristics, predictors, and outcomes of surgical explantation after transcatheter aortic valve replacement. J Am Coll Cardiol. 2020 Oct 20;76(16):1848–1859. doi:https://doi.org/10.1016/j.jacc.2020.08.048.
   PubMed Web of Science ®Google Scholar
• Ooms JF, Von der Thüsen JH, Budde RP, Van Mieghem NM. Treatment of a prematurely degenerated transcatheter heart valve in a patient on dialysis. JACC Cardiovasc Interv. 2020;13:e41–e42.
   Web of Science ®Google Scholar
• Maeda K, Kuratani T, Mizote I, et al. Midterm outcomes of transcatheter aortic valve replacement in dialysis patients with aortic valve stenosis. Circ J. 2019 Jun 25;83(7):1600–1606. doi:https://doi.org/10.1253/circj.CJ-19-0101.
   PubMed Web of Science ®Google Scholar